THRD Third Harmonic Bio Inc

Price (delayed)

$12.1

Market cap

$495.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.75

Enterprise value

$235.98M

Highlights
The company's EPS rose by 44% YoY and by 3.8% QoQ
THRD's quick ratio is up by 32% since the previous quarter and by 15% year-on-year
The equity fell by 7% YoY and by 2.1% QoQ

Key stats

What are the main financial stats of THRD
Market
Shares outstanding
40.95M
Market cap
$495.49M
Enterprise value
$235.98M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$29.6M
EBITDA
-$28.88M
Free cash flow
-$20.21M
Per share
EPS
-$0.75
Free cash flow per share
-$0.5
Book value per share
$6.47
Revenue per share
$0
TBVPS
$6.73
Balance sheet
Total assets
$270.52M
Total liabilities
$7.02M
Debt
$3.78M
Equity
$263.5M
Working capital
$261.58M
Liquidity
Debt to equity
0.01
Current ratio
66.1
Quick ratio
65.52
Net debt/EBITDA
8.98
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-10.6%
Return on equity
-10.9%
Return on invested capital
-435.5%
Return on capital employed
-11.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

THRD stock price

How has the Third Harmonic Bio stock price performed over time
Intraday
2.46%
1 week
-6.56%
1 month
-2.26%
1 year
116.85%
YTD
10.3%
QTD
-6.92%

Financial performance

How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$43.26M
Net income
-$29.6M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 19% YoY and by 4% QoQ
THRD's operating income is down by 3.2% year-on-year

Growth

What is Third Harmonic Bio's growth rate over time

Valuation

What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
1.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 44% YoY and by 3.8% QoQ
The stock's price to book (P/B) is 56% more than its last 4 quarters average of 1.2
The equity fell by 7% YoY and by 2.1% QoQ

Efficiency

How efficient is Third Harmonic Bio business performance
THRD's ROIC has soared by 64% YoY
The return on equity rose by 39% year-on-year and by 2.7% since the previous quarter
THRD's return on assets is up by 26% year-on-year

Dividends

What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for THRD.

Financial health

How did Third Harmonic Bio financials performed over time
THRD's quick ratio is up by 32% since the previous quarter and by 15% year-on-year
THRD's current ratio is up by 31% since the previous quarter and by 14% year-on-year
Third Harmonic Bio's debt is 99% lower than its equity
The company's debt to equity has shrunk by 50% YoY
Third Harmonic Bio's debt has decreased by 15% YoY and by 4.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.